Effects of azithromycin on ozone-induced airway neutrophilia and cytokine release

被引:16
作者
Criqui, GI
Solomon, C
Welch, BS
Ferrando, RE
Boushey, HA
Balmes, JR
机构
[1] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA
关键词
interleukin-8; macrolide antibiotics; neutrophils; ozone;
D O I
10.1034/j.1399-3003.2000.15e08.x
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Exposure of humans to ozone causes increased neutrophils and inflammatory cytokines in airway lining fluid. Recent research shows that macrolide antibiotics may reduce interleukin (IL)-8 production by bronchial epithelial cells and inhibit neutrophil chemotaxis, A double-blind, cross-over study was performed in which 12 healthy subjects underwent two separate 4-h exposures to 0.2 parts per million ozone while exercising intermittently. In the 73.5 h before exposure, subjects were pretreated with either 1,250 mg azithromycin or placebo. Sputum induction conducted 74 h pre- and 18 h post-exposure was used to measure total cells, per cent neutrophils, IL-6, and IL-8. There were significant (p<0.05) pre- to post-exposure increases in total cells, neutrophils, IL-6 and IL-8 in both the azithromycin and placebo arms. However, no significant differences were found between azithromycin and placebo conditions in the post- minus pre-exposure value for these variables. The results suggest that in healthy subjects, in the design used, azithromycin, in usual clinical doses, does not have anti-inflammatory effects on human airways as indicated in the measured variables.
引用
收藏
页码:856 / 862
页数:7
相关论文
共 21 条
  • [2] OZONE-INDUCED AIRWAY INFLAMMATION IN HUMAN-SUBJECTS AS DETERMINED BY AIRWAY LAVAGE AND BIOPSY
    ARIS, RM
    CHRISTIAN, D
    HEARNE, PQ
    KERR, K
    FINKBEINER, WE
    BALMES, JR
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (05): : 1363 - 1372
  • [3] Function of human alveolar macrophages after a 3-day course of azithromycin in healthy volunteers
    Aubert, JD
    Juillerat-Jeanneret, L
    Fioroni, P
    Dayer, P
    Plan, PA
    Leuenberger, P
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 1998, 11 (04) : 263 - 269
  • [4] BALDWIN DR, 1990, EUR RESPIR J, V3, P886
  • [5] Ozone-induced decrements in FEV(1) and FVC do not correlate with measures of inflammation
    Balmes, JR
    Chen, LL
    Scannell, C
    Tager, I
    Christian, D
    Hearne, PQ
    Kelly, T
    Aris, RM
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (03) : 904 - 909
  • [6] Bascom R, 1996, AM J RESP CRIT CARE, V153, P3, DOI 10.1164/ajrccm.153.1.8542133
  • [7] CHU HW, 1998, AM J RESP CRIT CARE, V157, pA24
  • [8] Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects
    Conte, JE
    Golden, J
    Duncan, S
    McKenna, E
    Lin, E
    Zurlinden, E
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (07) : 1617 - 1622
  • [9] Analysis of induced sputum after air and ozone exposures in healthy subjects
    Fahy, JV
    Wong, HH
    Liu, JT
    Boushey, HA
    [J]. ENVIRONMENTAL RESEARCH, 1995, 70 (02) : 77 - 83
  • [10] Inhibitory effect of erythromycin on interleukin 8 production by 1 alpha,25-dihydroxyvitamin D3-stimulated THP-1 cells
    Fujii, T
    Kadota, JI
    Morikawa, T
    Matsubara, Y
    Kawakami, K
    Iida, K
    Shirai, R
    Taniguchi, H
    Kaseda, M
    Kawamoto, S
    Kohno, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (06) : 1548 - 1551